Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2024;27(13):1984-1998.
doi: 10.2174/0113862073273633231113060429.

The Prognostic Hub Gene POLE2 Promotes BLCA Cell Growth via the PI3K/AKT Signaling Pathway

Dongzhen Jiang  1 , Huawei Zhang  1 , Bingde Yin  1 , Minke He  1 , Xuwei Lu  1 , Chang He  1
Affiliations

The Prognostic Hub Gene POLE2 Promotes BLCA Cell Growth via the PI3K/AKT Signaling Pathway

Dongzhen Jiang et al. Comb Chem High Throughput Screen. 2024.

Abstract

Background: BLCA is a common urothelial malignancy characterized by a high recurrence rate. Despite its prevalence, the molecular mechanisms underlying its development remain unclear.

Aims: This study aimed to explore new prognostic biomarkers and investigate the underlying mechanism of bladder cancer (BLCA).

Objective: The objective of this study is to identify key prognostic biomarkers for BLCA and to elucidate their roles in the disease.

Methods: We first collected the overlapping DEGs from GSE42089 and TCGA-BLCA samples for the subsequent weighted gene co-expression network analysis (WGCNA) to find a key module. Then, key module genes were analyzed by the MCODE algorithm, prognostic risk model, expression and immunohistochemical staining to identify the prognostic hub gene. Finally, the hub gene was subjected to clinical feature analysis, as well as cellular function assays.

Results: In WGCNA on 1037 overlapping genes, the blue module was the key module. After a series of bioinformatics analyses, POLE2 was identified as a prognostic hub gene in BLCA from potential genes (TROAP, POLE2, ANLN, and E2F8). POLE2 level was increased in BLCA and related to different clinical features of BLCA patients. Cellular assays showed that si-POLE2 inhibited BLCA proliferation, and si-POLE2+ 740Y-P in BLCA cells up-regulated the PI3K and AKT protein levels.

Conclusion: In conclusion, POLE2 was identified to be a promising prognostic biomarker as an oncogene in BLCA. It was also found that POLE2 exerts a promoting function by the PI3K/AKT signaling pathway in BLCA.

Keywords: Bladder cancer; PI3K/AKT signaling pathway; POLE2; WGCNA; cell growth.; prognosis.

PubMed Disclaimer

Similar articles

See all similar articles

References

    1. Ferlay J.; Soerjomataram I.; Dikshit R.; Eser S.; Mathers C.; Rebelo M.; Parkin D.M.; Forman D.; Bray F.; Cancer incidence and mortality worldwide: Sources, methods and major patterns in GLOBOCAN 2012. Int J Cancer 2015,136(5),E359-E386 - DOI - PubMed
    1. Qu G.; Liu Z.; Yang G.; Xu Y.; Xiang M.; Tang C.; Development of a prognostic index and screening of prognosis related genes based on an immunogenomic landscape analysis of bladder cancer. Aging 2021,13(8),12099-12112 - DOI - PubMed
    1. Lenis A.T.; Lec P.M.; Chamie K.; Mshs M.; Bladder cancer. JAMA 2020,324(19),1980-1991 - DOI - PubMed
    1. Dy G.W.; Gore J.L.; Forouzanfar M.H.; Naghavi M.; Fitzmaurice C.; Global burden of urologic cancers, 1990–2013. Eur Urol 2017,71(3),437-446 - DOI - PubMed
    1. Sievert K.D.; Amend B.; Nagele U.; Schilling D.; Bedke J.; Horstmann M.; Hennenlotter J.; Kruck S.; Stenzl A.; Economic aspects of bladder cancer: What are the benefits and costs? World J Urol 2009,27(3),295-300 - DOI - PubMed

MeSH terms

Substances

LinkOut - more resources